Find Tolvaptan manufacturers, exporters & distributors on PharmaCompass

Suanfarma, at the Core of a Better Life.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 15 USDMF, 8 JDMF, 8 EU WC, 2 KDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

37 API Suppliers
15 USDMF
8 JDMF
8 EU WC
2 KDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

78 FDF Dossiers, 19 FDA Orange Book, 37 Europe, 12 Canada, 10 Australia

78 FDF Dossiers
19 FDA Orange Book
37 Europe
12 Canada
10 Australia

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 3 Faran Shimi Pharmaceutical, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 DFE Pharma, 3 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 18 Kerry, 9 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 13 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 23 Direct Compression, 13 Co-Processed Excipients, 11 Thickeners and Stabilizers, 10 Disintegrants & Superdisintegrants, 10 Lubricants & Glidants, 9 Granulation, 5 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 5 Taste Masking, 3 Coating Systems & Additives, 1 Film Formers & Plasticizers, 1 Rheology Modifiers, 1 Emulsifying Agents, 1 Parenteral

excipientsByApplications
52 Fillers, Diluents & Binders
23 Direct Compression
13 Co-Processed Excipients
11 Thickeners and Stabilizers
10 Disintegrants & Superdisintegrants
10 Lubricants & Glidants
9 Granulation
5 Controlled & Modified Release
5 Chewable & Orodispersible Aids
5 Taste Masking
3 Coating Systems & Additives
1 Film Formers & Plasticizers
1 Rheology Modifiers
1 Emulsifying Agents
1 Parenteral

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

media
2 DATA COMPILATION #PharmaFlow
20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 33 Finished Drug Prices, 15 Annual Reports

globalSalesInformation
3 US Medicaid Prescriptions
33 Finished Drug Prices
15 Annual Reports

MARKET PLACE

9 APIs, 3 FDF Dossiers

marketPlace
9 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 5 US Exclusivities

patents
16 US Patents
5 US Exclusivities

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 8,898

MARKET PLACE

API

FDF

11INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

118,244,527

Annual Reports (USD Million)

9,774

Finished Drug Prices

93 RELATED EXCIPIENT COMPANIES

150EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 150683-30-0, Samsca, Opc-41061, Opc 41061, N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1h-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide, N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide

Molecular Formula

C₂₆H₂₅ClN₂O₃

Molecular Weight

448.9 g/mol

InChI Key

GYHCTFXIZSNGJT-UHFFFAOYSA-N

FDA UNII

21G72T1950

A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency.

Tolvaptan is a Vasopressin V2 Receptor Antagonist. The mechanism of action of tolvaptan is as a Vasopressin V2 Receptor Antagonist.

1 2D Structure

Tolvaptan

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide

2.1.2 InChI

InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)

2.1.3 InChI Key

GYHCTFXIZSNGJT-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C

2.2 Other Identifiers

2.2.1 UNII

21G72T1950

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1h-1-benzazepine

2. Opc 41061

3. Opc-41061

4. Opc41061

5. Samsca

2.3.2 Depositor-Supplied Synonyms

1. 150683-30-0

2. Samsca

3. Opc-41061

4. Opc 41061

5. N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1h-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide

6. N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide

7. (r)-(+)-tolvaptan

8. Tolvaptan (opc-41061)

9. Chembl344159

10. Opc-41061(tolvaptan)

11. Ncgc00183001-01

12. 21g72t1950

13. Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-

14. Jinarc

15. N-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1h-benzo[b]-azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide

16. Unii-21g72t1950

17. Benzazepine Derivative, 32

18. Tolvaptan [usan:inn:ban]

19. Hsdb 8196

20. Tolvaptan [inn]

21. Tolvaptan- Bio-x

22. Benzamide, N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-

23. Jynarque

24. 7-chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1h-1-benzazepine

25. Tolvaptan [jan]

26. Tolvaptan [mi]

27. Tolvaptan [usan]

28. Tolvaptan [vandf]

29. Tolvaptan [mart.]

30. Tolvaptan [who-dd]

31. Dsstox_cid_28706

32. Dsstox_rid_82975

33. Dsstox_gsid_48780

34. Tolvaptan [ema Epar]

35. Schembl242421

36. Gtpl2226

37. Tolvaptan [orange Book]

38. Dtxsid3048780

39. Bdbm35723

40. Chebi:32246

41. Hms3604l08

42. Hms3656k20

43. Hms3744a09

44. (r)-n-(4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1h-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide

45. Tox21_113256

46. Mfcd09838782

47. Pdsp1_001738

48. Pdsp2_001721

49. S2593

50. Akos015994735

51. Tolvaptan, >=98% (hplc), Powder

52. Ccg-269223

53. Cs-0572

54. Ks-1315

55. Ac-22748

56. Bt164486

57. Hy-17000

58. Am20090726

59. Cas-150683-30-0

60. Ft-0675287

61. Ft-0675288

62. Sw219182-1

63. Ab01565822_02

64. 683t300

65. A809063

66. L001628

67. Q426132

68. Sr-01000942265

69. Sr-01000942265-1

70. H-d-phe-pro-arg-5-amido-isophthalicacid-dimethylesteracetatesalt

71. (+-)-4'-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl) Carbonyl)-o-tolu-m-toluidide

72. (+-)-4'-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide

73. (+/-)-4'-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl) Carbonyl)-o-tolu-m-toluidide

74. 5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1h-benzazepine

75. 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methyl Benzoyl Amino) Benzoyl]-2,3,4,5-tetrahydro-1h-1-benzazepine

76. 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino) Benzoyl]-2,3,4,5-tetrahydro-1h-1-benzazepine

77. 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1h-1-benzazepine

78. N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-benzo[b]azepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide

79. N-[4-(7-chloro-5-hydroxy2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide

80. N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1h-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide

2.4 Create Date

2005-08-09

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₂₅ClN₂O₃
Molecular Weight	448.9 g/mol
XLogP3	4.8
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	3
Exact Mass	448.1553704 g/mol
Monoisotopic Mass	448.1553704 g/mol
Topological Polar Surface Area	69.6 Å²
Heavy Atom Count	32
Formal Charge	0
Complexity	674
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Samsca
PubMed Health	Tolvaptan (By mouth)
Drug Classes	Endocrine-Metabolic Agent
Drug Label	Tolvaptan is ()-4'-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl) carbonyl]-o-tolu-m-toluidide. The empirical formula is C26H25ClN2O3. Molecular weight is 448.94. The chemical structure is:SAMSCA tablets for oral use contain 15mg o...
Active Ingredient	Tolvaptan
Dosage Form	Tablet
Route	Oral
Strength	30mg; 15mg
Market Status	Prescription
Company	Otsuka America Pharm

2 of 2
Drug Name	Samsca
PubMed Health	Tolvaptan (By mouth)
Drug Classes	Endocrine-Metabolic Agent
Drug Label	Tolvaptan is ()-4'-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl) carbonyl]-o-tolu-m-toluidide. The empirical formula is C26H25ClN2O3. Molecular weight is 448.94. The chemical structure is:SAMSCA tablets for oral use contain 15mg o...
Active Ingredient	Tolvaptan
Dosage Form	Tablet
Route	Oral
Strength	30mg; 15mg
Market Status	Prescription
Company	Otsuka America Pharm

4.2 Therapeutic Uses

Vasopressin V2 Receptor Antagonist

National Library of Medicine, SIS; ChemIDplus Lite Record for Tolvaptan (150683-30-0). Available from, as of May 30, 2014: https://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp

Samsca is indicated for the treatment of clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction), including patients with heart failure and Syndrome of Inappropriate Antidiuretic Hormone (SIADH). /Included in US product label/

NIH; DailyMed. Current Medication Information for Samsca (Tolvaptan) Tablet (Revised: February 2014). Available from, as of June 5, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566

EXPL Autosomal dominant polycystic kidney disease (ADPKD) is characterized by bilateral renal cysts, kidney pain, hypertension, and progressive loss of renal function. It is a leading cause of end-stage renal disease and the most common inherited kidney disease in the United States. Despite its prevalence, disease-modifying treatment options do not currently exist. Tolvaptan is an orally active, selective arginine vasopressin V2 receptor antagonist already in use for hyponatremia. Tolvaptan exhibits dose-proportional pharmacokinetics with a half-life of approximately 12 hours. Metabolism occurs through the cytochrome P450 3A4 isoenzyme, and tolvaptan is a substrate for P-glycoprotein, resulting in numerous drug interactions. Recent research has highlighted the beneficial effect of tolvaptan on delaying the progression of ADPKD, which is the focus of this review. Pharmacologic, preclinical, and phase II and III clinical trial studies have demonstrated that tolvaptan is an effective treatment option that targets underlying pathogenic mechanisms of ADPKD. Tolvaptan delays the increase in total kidney volume (surrogate marker for disease progression), slows the decline in renal function, and reduces kidney pain. However, tolvaptan has significant adverse effects including aquaretic effects (polyuria, nocturia, polydipsia) and elevation of aminotransferase enzyme concentrations with the potential for acute liver failure. Appropriate patient selection is critical to optimize long-term benefits while minimizing adverse effects and hepatotoxic risk factors. Overall, tolvaptan is the first pharmacotherapeutic intervention to demonstrate significant benefit in the treatment of ADPKD, but practitioners and regulatory agencies must carefully weigh the risks versus benefits. Additional research should focus on incidence and risk factors of liver injury, cost-effectiveness, clinical management of drug-drug interactions, and long-term disease outcomes.

PMID:24706579 Baur BP et al; Pharmacotherapy. 2014 Apr 7. doi: 10.1002/phar.1421. (Epub ahead of print)

Tolvaptan is not indicated for the treatment of hypovolemic hyponatremia. The manufacturer states that tolvaptan should not be used in patients who require urgent intervention to raise serum sodium concentrations to prevent or treat serious neurologic manifestations. In addition, it has not been established that using tolvaptan to increase serum sodium concentrations provides symptomatic benefit to patients

American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 2853

4.3 Drug Warning

/BOXED WARNING/ WARNING: INITIATE AND RE-INITIATE IN A HOSPITAL AND MONITOR SERUM SODIUM. Samsca should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely. Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or advanced liver disease, slower rates of correction may be advisable.

Tolvaptan therapy should be initiated or reinitiated only in a hospital setting, where serum sodium concentrations and therapeutic response can be monitored closely. Too rapid a correction of hyponatremia (e.g., increases in serum sodium concentration exceeding 12 mEq/L over 24 hours) may cause osmotic demyelination syndrome, resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma, or death. Slower rates of correction may be advisable in susceptible patients, including those with severe malnutrition, alcoholism, or advanced liver disease. Patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) or very low baseline serum sodium concentrations may be at increased risk for too rapid a correction of serum sodium concentration. Fluid restriction during the first 24 hours of tolvaptan therapy may increase the risk of overly rapid correction of serum sodium concentration and generally should be avoided.

American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 2854

Samsca can cause serious and potentially fatal liver injury. In a placebo-controlled and open label extension study of chronically administered tolvaptan in patients with autosomal dominant polycystic kidney disease, cases of serious liver injury attributed to tolvaptan were observed. An increased incidence of ALT greater than three times the upper limit of normal was associated with tolvaptan (42/958 or 4.4%) compared to placebo (5/484 or 1.0%). Cases of serious liver injury were generally observed starting 3 months after initiation of tolvaptan although elevations of ALT occurred prior to 3 months. Patients with symptoms that may indicate liver injury, including fatigue, anorexia, right upper abdominal discomfort, dark urine or jaundice should discontinue treatment with Samsca. Limit duration of therapy with Samsca to 30 days. Avoid use in patients with underlying liver disease, including cirrhosis, because the ability to recover from liver injury may be impaired

The U.S. Food and Drug Administration (FDA) has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver injury, potentially requiring liver transplant or death. Samsca is used to treat low sodium levels in the blood. An increased risk of liver injury was observed in recent large clinical trials evaluating Samsca for a new use in patients with autosomal dominant polycystic kidney disease (ADPKD)

US FDA; FDA Drug Safety Communication: FDA Limits Duration and Usage of Samsca (Tolvaptan) Due to Possible Liver Injury Leading to Organ Transplant or Death (April 30, 2013). Available from, as of June 5, 2014: https://www.fda.gov/Drugs/DrugSafety/ucm350062.htm

For more Drug Warnings (Complete) data for Tolvaptan (15 total), please visit the HSDB record page.

4.4 Drug Indication

Jinarc is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adults with CKD stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease.

Treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (SIADH).

Treatment of dilutional hyponatraemia, Treatment of polycystic kidney disease

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Antidiuretic Hormone Receptor Antagonists

Endogenous compounds and drugs that inhibit or block the activity of ANTIDUIRETIC HORMONE RECEPTORS. (See all compounds classified as Antidiuretic Hormone Receptor Antagonists.)

5.2 FDA Pharmacological Classification

5.2.1 Active Moiety

TOLVAPTAN

5.2.2 FDA UNII

21G72T1950

5.2.3 Pharmacological Classes

Vasopressin V2 Receptor Antagonists [MoA]; Vasopressin V2 Receptor Antagonist [EPC]

5.3 ATC Code

C03XA01

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

C - Cardiovascular system

C03 - Diuretics

C03X - Other diuretics

C03XA - Vasopressin antagonists

C03XA01 - Tolvaptan

5.4 Absorption, Distribution and Excretion

In a study in patients with creatinine clearances ranging from 10-124 mL/min administered a single dose of 60 mg tolvaptan, AUC and Cmax of plasma tolvaptan were less than doubled in patients with severe renal impairment relative to the controls. The peak increase in serum sodium was 5-6 mEq/L, regardless of renal function, but the onset and offset of tolvaptan's effect on serum sodium were slower in patients with severe renal impairment.

In healthy subjects the pharmacokinetics of tolvaptan after single doses of up to 480 mg and multiple doses up to 300 mg once daily have been examined. Area under the curve (AUC) increases proportionally with dose. After administration of doses > or = 60 mg, however, Cmax increases less than proportionally with dose. The pharmacokinetic properties of tolvaptan are stereospecific, with a steady-state ratio of the S-(-) to the R-(+) enantiomer of about 3. The absolute bioavailability of tolvaptan is unknown. At least 40% of the dose is absorbed as tolvaptan or metabolites. Peak concentrations of tolvaptan are observed between 2 and 4 hours post-dose. Food does not impact the bioavailability of tolvaptan. In vitro data indicate that tolvaptan is a substrate and inhibitor of P-gp. Tolvaptan is highly plasma protein bound (99%) and distributed into an apparent volume of distribution of about 3 L/kg. Tolvaptan is eliminated entirely by non-renal routes and mainly, if not exclusively, metabolized by CYP 3A. After oral dosing, clearance is about 4 mL/min/kg and the terminal phase half-life is about 12 hours. The accumulation factor of tolvaptan with the once-daily regimen is 1.3 and the trough concentrations amount to > or = 16% of the peak concentrations, suggesting a dominant half-life somewhat shorter than 12 hours. There is marked inter-subject variation in peak and average exposure to tolvaptan with a percent coefficient of variation ranging between 30 and 60%.

In patients with hyponatremia of any origin the clearance of tolvaptan is reduced to about 2 mL/min/kg. Moderate or severe hepatic impairment or congestive heart failure decrease the clearance and increase the volume of distribution of tolvaptan, but the respective changes are not clinically relevant. Exposure and response to tolvaptan in subjects with creatinine clearance ranging between 79 and 10 mL/min and patients with normal renal function are not different.

In healthy subjects receiving a single dose of Samsca 60 mg, the onset of the aquaretic and sodium increasing effects occurs within 2 to 4 hours post-dose. A peak effect of about a 6 mEq increase in serum sodium and about 9 mL/min increase in urine excretion rate is observed between 4 and 8 hours post-dose; thus, the pharmacological activity lags behind the plasma concentrations of tolvaptan. About 60% of the peak effect on serum sodium is sustained at 24 hours post-dose, but the urinary excretion rate is no longer elevated by this time. Doses above 60 mg tolvaptan do not increase aquaresis or serum sodium further. The effects of tolvaptan in the recommended dose range of 15 to 60 mg once daily appear to be limited to aquaresis and the resulting increase in sodium concentration.

For more Absorption, Distribution and Excretion (Complete) data for Tolvaptan (12 total), please visit the HSDB record page.

5.5 Metabolism/Metabolites

Repeated dosing of female rats reduced systemic exposure to tolvaptan. Analysis of the serum samples for metabolites DM-4103 and DM-4107 revealed increases in the concentrations of these metabolites following repeated dosing, and explained the reduction in serum tolvaptan concentrations. Furthermore, tolvaptan was shown to induce hepatic drug-metabolising enzymes (cytochrome b5 content and aminopyrine N-demethylase activity) in female rats after 7 days dosing at 300 mg/kg/day. Tolvaptan was both a substrate for, and inhibitor of, MDR1-mediated transport.

European Medicines Agency (EMA), Committee for Medicinal Products for Human Use (CHMP), European Public Assessment Report (EPAR): Samsca (Tolvaptan) p.12 (2009). Available from, as of June 5, 2014: https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000980/WC500048715.pdf

Tolvaptan is extensively metabolized in all species investigated. In vitro studies with rat liver supernatant produced a number of metabolites of tolvaptan. Hydroxylation of the benzazepine ring produced metabolites DM-4110, DM-4111 and DM-4119. Cleavage of the bond between the 1 and 2 positions of the benzazepine ring produced metabolites DM-4103, DM-4104, DM-4105 and DM- 4107. Oxidation of the hydroxyl group at the 5 position in the benzazepine ring produced MOP-21826.

European Medicines Agency (EMA), Committee for Medicinal Products for Human Use (CHMP), European Public Assessment Report (EPAR): Samsca (Tolvaptan) p.11 (2009). Available from, as of June 5, 2014: https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000980/WC500048715.pdf

Tolvaptan is mainly, if not exclusively, metabolized in the liver by cytochrome P-450 (CYP) isoenzyme 3A; the drug also is a weak inhibitor of CYP3A and a substrate and inhibitor of the P-glycoprotein transport system. Compared with tolvaptan, metabolites of the drug have little or no antagonist activity for human V2 receptors.

American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 2856

Tolvaptan is metabolized extensively in humans by the CYP3A4/5 system with seven metabolites (DM-4103, DM-4104, DM-4105, DM-4107, DM-4110, DM-4111, DM-4119) detected in the plasma, urine, and faeces of all subjects in a 14C mass balance study. After administration of (14)C-tolvaptan, 13 metabolites were identified in human plasma. Tolvaptan and identified metabolites accounted for about 70% of administered radioactivity. The predominant metabolite, with >50% of the total dose using the mass balance approach was DM-4103. The terminal elimination half-life of DM-4103 is approximatley 183 hours and after multiple dosing DM-4103 shows accumulation by day 28, but this appears pharmacologically inactive in the concentrations achieved using clinically relevant doses. Only 3% of the radioactivity was due to unchanged tolvaptan in the plasma.

European Medicines Agency (EMA), Committee for Medicinal Products for Human Use (CHMP), European Public Assessment Report (EPAR): Samsca (Tolvaptan) p.17 (2009). Available from, as of June 5, 2014: https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000980/WC500048715.pdf

5.6 Biological Half-Life

After IV administration, a half-life was estimated to be 3.5 hours, but it is suggested that this value most likely represents a distribution half-life and not a true elimination half-life.

The terminal phase half-life is about 12 hours.

Although tolvaptan is poorly soluble in water, following single dose of 30-480 mg, it is absorbed rapidly with a median time to peak plasma concentrations of about 2 hours (range of 1-12 hours) in healthy subjects. The mean (SD) of elimination half life is 7.8 (4.9) hours.

5.7 Mechanism of Action

Tolvaptan is a vasopressin antagonist that blocks the binding of arginine vasopressin (AVP) at the V2 receptors of the distal portions of the nephron. Animal pharmacology studies indicated that tolvaptan should increase excretion of water without increasing excretion of electrolytes (aquaresis) and thus offer a means of correcting serum sodium concentration by inducing excretion of water without loss of serum electrolytes. Tolvaptan is about 29 times more selective for V2 receptors than for V1a receptors with virtually no binding to V1b receptors.

European Medicines Agency (EMA), Committee for Medicinal Products for Human Use (CHMP), European Public Assessment Report (EPAR): Samsca (Tolvaptan) p.18 (2009). Available from, as of June 5, 2014: https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000980/WC500048715.pdf

Tolvaptan is a selective vasopressin V2-receptor antagonist with an affinity for the V2-receptor that is 1.8 times that of native arginine vasopressin (AVP). Tolvaptan affinity for the V2-receptor is 29 times greater than for the V1a-receptor. When taken orally, 15 to 60 mg doses of tolvaptan antagonize the effect of vasopressin and cause an increase in urine water excretion that results in an increase in free water clearance (aquaresis), a decrease in urine osmolality, and a resulting increase in serum sodium concentrations. Urinary excretion of sodium and potassium and plasma potassium concentrations are not significantly changed. Tolvaptan metabolites have no or weak antagonist activity for human V2-receptors compared with tolvaptan. Plasma concentrations of native AVP may increase (avg. 2-9 pg/mL) with tolvaptan administration.

API SUPPLIERS

01

Biophore India Pharmaceuticals Pvt...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DCAT Week

Attending

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF

Click Us!

CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

Product Web Link

02

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

03

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

04

ASolution Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

ASolution Pharmaceuticals: Your Partner for cGMP Development & Manufacturing Services – Supplying APIs, FDFs, and Specialty Molecules.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

05

Neuland Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

DCAT Week

Exhibiting

Neuland Laboratories- A dedicated 100% API provider.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

Product Web Link

06

Extrovis AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

07

Zhejiang Huahai Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

08

Sun Pharmaceutical Industries Limi...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

09

Olon S.p.A

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

10

MSN Laboratories

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIO Partnering at JPM

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

LGM Pharma

U.S.A

PharmaVenue

Not Confirmed

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Tolvaptan

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.

02

Metrochem API Private Limited

India

PharmaVenue

Not Confirmed

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

India

Virtual Booth

Digital Content

Tolvaptan

About the Company :

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product ...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer

03

ASolution Pharmaceuticals

India

PharmaVenue

Not Confirmed

ASolution Pharmaceuticals: Your Partner for cGMP Development & Manufacturing Services – Supplying APIs, FDFs, and Specialty Molecules.

Contact Supplier

India

Virtual Booth

Digital Content

Tolvaptan

About the Company : Since 2010, our dedication to our clientele has been unwavering in addressing pharmaceutical hurdles, regardless of scale. We prioritize integrity, responsiveness, and punctuality,...

Since 2010, our dedication to our clientele has been unwavering in addressing pharmaceutical hurdles, regardless of scale. We prioritize integrity, responsiveness, and punctuality, embedding our values into every endeavor. Our aim is to cultivate mutually beneficial relationships with customers, suppliers, and ourselves, fostering sustainable growth. Empowered by visionary leadership and a quality-driven team, ASolution is steadfast in providing innovative solutions to challenges such as Process Development, Optimization, Drug Product and Substance Manufacturing, and more.

04

Neuland Laboratories

India

DCAT Week

Exhibiting

Neuland Laboratories- A dedicated 100% API provider.

Contact Supplier

India

Virtual Booth

Digital Content

Tolvaptan

About the Company : Established in 1984, Neuland Laboratories Limited is a publicly listed company headquartered in Hyderabad, India. The company provides solutions across the entire spectrum of the p...

Established in 1984, Neuland Laboratories Limited is a publicly listed company headquartered in Hyderabad, India. The company provides solutions across the entire spectrum of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying NCEs and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. Neuland’s expertise is in the manufacturing of APIs and advanced intermediates from its USFDA-approved facilities. Its core competency lies in the application of powerful process chemistry to manufacturing in a regulatory-compliant environment.

Portfolio PDF

Product Web Link

India

PharmaVenue

Not Confirmed

Smilax Laboratories Limited

India

PharmaVenue

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

India

Virtual Booth

Digital Content

Tolvaptan

About the Company : Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets f...

Smilax Laboratories Limited is a research-driven, vertically integrated pharmaceutical company manufacturing Active Pharmaceutical Ingredients, API Intermediates and NDDS/Pellets for the generics market across the world. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today.Set up in 2005, Smilax has emerged a reliable supplier of generic products in the global market today. Smilax manufactures APIs and API Intermediates at its state-of-the-art manufacturing facilities located at Hyderabad, Telangana and Visakhapatnam, Andhra Pradesh, India. Supported by a highly qualified and competent technical team, and endowed with strengths in research and development, Smilax continues to expand its presence in the world of pharmaceuticals.

Product Web Link

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q1","strtotime":1611167400,"product":"TOLVAPTAN AMORPHOUS","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"TO THE ORDER OF","customerCountry":"JORDAN","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"8780.6","totalValueFC":"88901.8","currency":"USD","unitRateINR":650200,"date":"21-Jan-2021","totalValueINR":"6502000","totalValueInUsd":"88901.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"8063947","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q2","strtotime":1618943400,"product":"TOLVAPTAN","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"KEFALLINIA","customer":"TO THE ORDER OF--","customerCountry":"ICELAND","quantity":"12.00","actualQuantity":"12","unit":"KGS","unitRateFc":"16006.4","totalValueFC":"185886.8","currency":"USD","unitRateINR":1153258.3333333333,"date":"21-Apr-2021","totalValueINR":"13839100","totalValueInUsd":"185886.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"1261819","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q2","strtotime":1619202600,"product":"TOLVAPTAN AMORPHOUS IH (TAX INVOICE NO:1 902200060 DATED:12.04.2021)","address":"10-2-196,EAST MARREDPALLY","city":"SECUNDERABAD.AP","supplier":"REFARMED CHEMICALS","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER OF","customerCountry":"TURKEY","quantity":"5.00","actualQuantity":"5000","unit":"GMS","unitRateFc":"19.6","totalValueFC":"94639.7","currency":"USD","unitRateINR":1409.1672000000001,"date":"24-Apr-2021","totalValueINR":"7045836","totalValueInUsd":"94639.7","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"1345019","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"10-2-196,EAST MARREDPALLY, SECUNDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q2","strtotime":1621276200,"product":"TOLVAPTAN AMORPHOUS","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"RIYADH","customer":"TO THE ORDER OF","customerCountry":"SAUDI ARABIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"9078.1","totalValueFC":"53576.9","currency":"USD","unitRateINR":654079.29000000004,"date":"18-May-2021","totalValueINR":"3924475.74","totalValueInUsd":"53576.9","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"1834922","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1628706600,"product":"TOLVAPTAN","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"HIKMA PHARMACEUTICALS","customerCountry":"JORDAN","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"9158.9","totalValueFC":"88974.3","currency":"USD","unitRateINR":659900,"date":"12-Aug-2021","totalValueINR":"6599000","totalValueInUsd":"88974.3","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"3797977","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1633458600,"product":"TOLVAPTAN","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"DEVA HOLDING AS","customerCountry":"TURKEY","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"17000","totalValueFC":"4885.7","currency":"USD","unitRateINR":1220000,"date":"06-Oct-2021","totalValueINR":"366000","totalValueInUsd":"4885.7","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"5123628","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638556200,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"RIYADH","customer":"HIKMA PHARMACEUTICALS","customerCountry":"SAUDI ARABIA","quantity":"4.30","actualQuantity":"4.3","unit":"KGS","unitRateFc":"9000","totalValueFC":"37984.2","currency":"USD","unitRateINR":666279.06976744183,"date":"04-Dec-2021","totalValueINR":"2865000","totalValueInUsd":"37984.2","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"6497186","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640543400,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"REYKJAVIK KEFLAVIK","customer":"M\/S.CORIPHARMA EHF.,","customerCountry":"ICELAND","quantity":"7.00","actualQuantity":"7","unit":"KGS","unitRateFc":"13950","totalValueFC":"97552.4","currency":"USD","unitRateINR":1051142.857142857,"date":"27-Dec-2021","totalValueINR":"7358000","totalValueInUsd":"97552.4","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"7055529","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1640543400,"product":"TOLVAPTAN API","address":"5-5-35\/102&103,PLOT NO 22,23,SY NO ,379,380,381,PRASHANTH NAGAR,KP","city":"HYDERABAD,TELANGANA","supplier":"EXTROVIS AG","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ULKAR HOLDING","customerCountry":"TURKEY","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"7500","totalValueFC":"3619.4","currency":"USD","unitRateINR":546000,"date":"27-Dec-2021","totalValueINR":"273000","totalValueInUsd":"3619.4","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"7040876","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"5-5-35\/102&103,PLOT NO 22,23,SY NO ,379,380,381,PRASHANTH NAGAR,KP, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642617000,"product":"PHARMACEUTICAL PRODUCTS TOLVAPTAN","address":"ALKEM HOUSE, DEVASHISH ADJACENT T O,MATULYA CENTRE, SENAPATI BAPAT MA","city":"MUMBAI,MAHARASHTRA","supplier":"ALKEM LABORATORIES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ULKAR HOLDING","customerCountry":"TURKEY","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"15000","totalValueFC":"4443.3","currency":"USD","unitRateINR":1103333.3333333335,"date":"20-Jan-2022","totalValueINR":"331000","totalValueInUsd":"4443.3","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"7622293","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"ALKEM HOUSE, DEVASHISH ADJACENT T O,MATULYA CENTRE, SENAPATI BAPAT MA, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643567400,"product":"TOLVAPTAN MATERIAL CODE:TOV00 BATCH NO:T","address":"SITE NO. 1A,,BOMMASANDRA INDUSTRIA L AREA","city":"IVTH PHASE JIGANI LINK ROAD,KARNATA","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"APOTEX INC","customerCountry":"CANADA","quantity":"26.84","actualQuantity":"26.84","unit":"KGS","unitRateFc":"4300","totalValueFC":"113902.6","currency":"USD","unitRateINR":316132.63785394933,"date":"31-Jan-2022","totalValueINR":"8485000","totalValueInUsd":"113902.6","indian_port":"BANGALORE AIR","hs_no":"29339990","bill_no":"7873759","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"SITE NO. 1A,,BOMMASANDRA INDUSTRIA L AREA, IVTH PHASE JIGANI LINK ROAD,KARNATA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1654713000,"product":"TOLVAPTAN (TAX INVOICE NO:1900225152 DT","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"TO THE ORDER OF","customerCountry":"BANGLADESH","quantity":"0.20","actualQuantity":"0.2","unit":"KGS","unitRateFc":"5000","totalValueFC":"935.7","currency":"USD","unitRateINR":365000,"date":"09-Jun-2022","totalValueINR":"73000","totalValueInUsd":"935.7","indian_port":"HYDERABAD AIR","hs_no":"29039110","bill_no":"2012765","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655317800,"product":"TOLVAPTAN AMORPHOUS","address":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD","city":"HYDERABAD","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"TO THE ORDER OF","customerCountry":"TURKEY","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"9000","totalValueFC":"884.4","currency":"USD","unitRateINR":690000,"date":"16-Jun-2022","totalValueINR":"69000","totalValueInUsd":"884.4","indian_port":"HYDERABAD AIR","hs_no":"29039110","bill_no":"2172702","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE, PLOT NO. C-24,INDUSTRIAL HYDERABAD, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"TOLVAPTAN","address":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI GHTS, MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE PHARMACEUTICALS PRIVATE ","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU TOSUN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"10.50","actualQuantity":"10.5","unit":"KGS","unitRateFc":"3600","totalValueFC":"37197.8","currency":"USD","unitRateINR":276380.95238095237,"date":"18-Jun-2022","totalValueINR":"2902000","totalValueInUsd":"37197.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"2215735","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI GHTS, MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1656095400,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"RIYADH","customer":"JAZEERA PHARMACEUTICAL","customerCountry":"SAUDI ARABIA","quantity":"27.00","actualQuantity":"27","unit":"KGS","unitRateFc":"9000","totalValueFC":"240106.8","currency":"USD","unitRateINR":693777.77777777775,"date":"25-Jun-2022","totalValueINR":"18732000","totalValueInUsd":"240106.8","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"2388960","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1656700200,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"REYKJAVIK KEFLAVIK","customer":"M\/S.CORIPHARMA EHF.,","customerCountry":"ICELAND","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"13995","totalValueFC":"20335.4","currency":"USD","unitRateINR":1078000,"date":"02-Jul-2022","totalValueINR":"1617000","totalValueInUsd":"20335.4","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"2560220","productDescription":"API","marketType":"REGULATED MARKET","country":"ICELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662575400,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"10000","totalValueFC":"244568.8","currency":"USD","unitRateINR":784000,"date":"08-Sep-2022","totalValueINR":"19600000","totalValueInUsd":"244568.8","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"4052155","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675362600,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"ALGIERS","customer":"BNP PARIBAS.,","customerCountry":"ALGERIA","quantity":"8.50","actualQuantity":"8.5","unit":"KGS","unitRateFc":"9500","totalValueFC":"79137.9","currency":"USD","unitRateINR":768941.17647058819,"date":"03-Feb-2023","totalValueINR":"6536000","totalValueInUsd":"79137.9","indian_port":"HYDERABAD AIR","hs_no":"29333990","bill_no":"7494737","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ALGERIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"TOLVAPTAN MATERIAL CODE:TOV00 BATCH NO.T","address":"SITE NO. 1A,,BOMMASANDRA INDUSTRIA L AREA","city":"IVTH PHASE JIGANI LINK ROAD,KARNATA","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"APOTEX INC","customerCountry":"CANADA","quantity":"25.61","actualQuantity":"25.61","unit":"KGS","unitRateFc":"4300","totalValueFC":"108935.7","currency":"USD","unitRateINR":351308.08278016403,"date":"28-Feb-2023","totalValueINR":"8997000","totalValueInUsd":"108935.7","indian_port":"BANGALORE AIR","hs_no":"29339990","bill_no":"8144990","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"SITE NO. 1A,,BOMMASANDRA INDUSTRIA L AREA, IVTH PHASE JIGANI LINK ROAD,KARNATA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"TOLVAPTAN MATERIAL CODE:TOV00 BATCH NO.T","address":"SITE NO. 1A,,BOMMASANDRA INDUSTRIA L AREA","city":"IVTH PHASE JIGANI LINK ROAD,KARNATA","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"APOTEX INC","customerCountry":"CANADA","quantity":"40.42","actualQuantity":"40.42","unit":"KGS","unitRateFc":"4300","totalValueFC":"171957.8","currency":"USD","unitRateINR":351360.71251855517,"date":"28-Feb-2023","totalValueINR":"14202000","totalValueInUsd":"171957.8","indian_port":"BANGALORE AIR","hs_no":"29339990","bill_no":"8144993","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"SITE NO. 1A,,BOMMASANDRA INDUSTRIA L AREA, IVTH PHASE JIGANI LINK ROAD,KARNATA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"TOLVAPTAN IH","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"SINGAPORE","customer":"TO THE ORDER OF","customerCountry":"SINGAPORE","quantity":"4.66","actualQuantity":"4.66","unit":"KGS","unitRateFc":"11500","totalValueFC":"53093.6","currency":"USD","unitRateINR":940987.12446351931,"date":"28-Feb-2023","totalValueINR":"4385000","totalValueInUsd":"53093.6","indian_port":"HYDERABAD AIR","hs_no":"29420090","bill_no":"8131117","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SINGAPORE","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694111400,"product":"TOLVAPTAN","address":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI","city":"HYDERABAD,TELANGANA","supplier":"AURORE PHARMACEUTICALS PRIVATE ","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU TOSUN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"3600","totalValueFC":"1734.8","currency":"USD","unitRateINR":288000,"date":"08-Sep-2023","totalValueINR":"144000","totalValueInUsd":"1734.8","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"3794053","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694975400,"product":"TOLVAPTAN (0.165 KGS)","address":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI","city":"HYDERABAD,TELANGANA","supplier":"AURORE PHARMACEUTICALS PRIVATE ","supplierCountry":"INDIA","foreign_port":"HANOI - NOIBAI","customer":"PHARBACO CENTRAL PHARMACEUTICAL ","customerCountry":"VIETNAM","quantity":"0.17","actualQuantity":"0.165","unit":"KGS","unitRateFc":"6500","totalValueFC":"999.9","currency":"USD","unitRateINR":503030.30303030298,"date":"18-Sep-2023","totalValueINR":"83000","totalValueInUsd":"999.9","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"4008846","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"VIETNAM, DEMOCRATIC REP. OF","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695839400,"product":"TOLVAPTAN","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"TO THE ORDER OF","customerCountry":"BANGLADESH","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"7000","totalValueFC":"20757","currency":"USD","unitRateINR":574333.33333333337,"date":"28-Sep-2023","totalValueINR":"1723000","totalValueInUsd":"20757","indian_port":"Hyderabad Air","hs_no":"29039110","bill_no":"4242515","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696530600,"product":"TOLVAPTAN","address":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI","city":"HYDERABAD,TELANGANA","supplier":"AURORE PHARMACEUTICALS PRIVATE ","supplierCountry":"INDIA","foreign_port":"SHENZHEN","customer":"GUANGZHOU TOSUN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3600","totalValueFC":"7040.8","currency":"USD","unitRateINR":293000,"date":"06-Oct-2023","totalValueINR":"586000","totalValueInUsd":"7040.8","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"4430744","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT 68,69, 2ND FLOOR, JUBILEE,HEI, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703097000,"product":"TOLVAPTAN","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"POPULAR PHARMACEUTICALS LTD.","customerCountry":"BANGLADESH","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"6500","totalValueFC":"32026.7","currency":"USD","unitRateINR":533200,"date":"21-Dec-2023","totalValueINR":"2666000","totalValueInUsd":"32026.7","indian_port":"Hyderabad Air","hs_no":"29039110","bill_no":"6193946","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709490600,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"RIYADH","customer":"JAZEERA PHARMACEUTICAL","customerCountry":"SAUDI ARABIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"9000","totalValueFC":"89011.6","currency":"USD","unitRateINR":739115,"date":"04-Mar-2024","totalValueINR":"7391150","totalValueInUsd":"89011.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8043060","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711045800,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"LAHORE","customer":"CCL PHARMACEUTICALS PVT ","customerCountry":"PAKISTAN","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"15","totalValueFC":"2185","currency":"USD","unitRateINR":1209.5454666666667,"date":"22-Mar-2024","totalValueINR":"181431.82","totalValueInUsd":"2185","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8541563","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711737000,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"13.08","actualQuantity":"13.08","unit":"KGS","unitRateFc":"10000","totalValueFC":"129375.5","currency":"USD","unitRateINR":821314.98470948008,"date":"30-Mar-2024","totalValueINR":"10742800","totalValueInUsd":"129375.5","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"8749148","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712860200,"product":"TOLVAPTAN (AMORPHOUS)","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"BANGKOK","customer":"SPG INTERNATIONAL CO. ","customerCountry":"THAILAND","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"8000","totalValueFC":"7834.6","currency":"USD","unitRateINR":654247,"date":"12-Apr-2024","totalValueINR":"654247","totalValueInUsd":"7834.6","indian_port":"Hyderabad Air","hs_no":"29039110","bill_no":"9080959","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"THAILAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718130600,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"UPSHER-SMITH LABORATORIES","customerCountry":"UNITED STATES","quantity":"18.00","actualQuantity":"18","unit":"KGS","unitRateFc":"9500","totalValueFC":"169198.6","currency":"USD","unitRateINR":784700,"date":"12-Jun-2024","totalValueINR":"14124600","totalValueInUsd":"169198.6","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"1618807","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722796200,"product":"TOLVAPTAN","address":"4th floor, Plot No 532 and 534, Uptown","city":"hyderabad","supplier":"GLOBAL PHARMA TEK INDIA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIAL ","customerCountry":"UNITED STATES","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"35","totalValueFC":"5185.6","currency":"USD","unitRateINR":2899.75,"date":"05-Aug-2024","totalValueINR":"434962.5","totalValueInUsd":"5185.6","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"2973533","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"4th floor, Plot No 532 and 534, Uptown, hyderabad","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726511400,"product":"TOLVAPTAN","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"BASLE","customer":"AIRPHARM","customerCountry":"SWITZERLAND","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"5940","totalValueFC":"23453.3","currency":"USD","unitRateINR":491353.84000000003,"date":"17-Sep-2024","totalValueINR":"1965415.36","totalValueInUsd":"23453.3","indian_port":"Hyderabad Air","hs_no":"29039110","bill_no":"4086680","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726511400,"product":"TOLVAPTAN","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"BASLE","customer":"AIRPHARM","customerCountry":"SWITZERLAND","quantity":"4.00","actualQuantity":"4","unit":"KGS","unitRateFc":"5940","totalValueFC":"23453.3","currency":"USD","unitRateINR":491353.84000000003,"date":"17-Sep-2024","totalValueINR":"1965415.36","totalValueInUsd":"23453.3","indian_port":"Hyderabad Air","hs_no":"29039110","bill_no":"4092950","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1727202600,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"CHICAGO O\\'HARE INT\\'L","customer":"UPSHER-SMITH LABORATORIES","customerCountry":"UNITED STATES","quantity":"29.50","actualQuantity":"29.5","unit":"KGS","unitRateFc":"9500","totalValueFC":"277236.1","currency":"USD","unitRateINR":787550,"date":"25-Sep-2024","totalValueINR":"23232725","totalValueInUsd":"277236.1","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"4339913","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728585000,"product":"TOLVAPTAN","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"1.92","actualQuantity":"1.92","unit":"KGS","unitRateFc":"10000","totalValueFC":"18871.4","currency":"USD","unitRateINR":825885.41666666674,"date":"11-Oct-2024","totalValueINR":"1585700","totalValueInUsd":"18871.4","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"4771433","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729708200,"product":"TOLVAPTAN","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"BIOFARMA PHARMACEUTICALS","customerCountry":"TURKEY","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"20000","totalValueFC":"296769","currency":"USD","unitRateINR":1662432,"date":"24-Oct-2024","totalValueINR":"24936480","totalValueInUsd":"296769","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"5105463","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732559400,"product":"TOLVAPTAN POVIDONE PREMIX IH","address":"HETERO CORPORATE, NO. 7-2-A2,,INDU","city":"HYDERABAD,TELANGANA","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"INCHEON","customer":"RIHU HEALTHCARE","customerCountry":"REPUBLIC OF KOREA","quantity":"0.18","actualQuantity":"0.18","unit":"KGS","unitRateFc":"20000","totalValueFC":"3062.4","currency":"USD","unitRateINR":1435705.5555555555,"date":"26-Nov-2024","totalValueINR":"258427","totalValueInUsd":"3062.4","indian_port":"Vizag-HIPL SEZ","hs_no":"29349990","bill_no":"5919566","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,,INDU, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1732645800,"product":"TOLVAPTAN POVIDONE PREMIX IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"ILKO ILAC SANAYI ","customerCountry":"TURKEY","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"10000","totalValueFC":"19184.5","currency":"USD","unitRateINR":809473.5,"date":"27-Nov-2024","totalValueINR":"1618947","totalValueInUsd":"19184.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29349990","bill_no":"5956765","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Import","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q1","strtotime":1609957800,"product":"TOLVAPTAN","address":"201\/301, CORPORATE ENCLAVE,B D SAWANT MARG, CHAKALA,","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"37.20","actualQuantity":"37.2","unit":"KGS","unitRateFc":"6500","totalValueFC":"246141.5","currency":"USD","unitRateINR":"483925","date":"07-Jan-2021","totalValueINR":"18002010","totalValueInUsd":"246141.5","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2268384","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"","customerAddress":"201\/301, CORPORATE ENCLAVE,B D SAWANT MARG, CHAKALA,"},{"dataSource":"API Import","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q1","strtotime":1612549800,"product":"TOLVAPTAN","address":"201\/301, CORPORATE ENCLAVE,B D SAWANT MARG, CHAKALA,","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"14.54","actualQuantity":"14.54","unit":"KGS","unitRateFc":"6500","totalValueFC":"95799.4","currency":"USD","unitRateINR":"479700","date":"06-Feb-2021","totalValueINR":"6974838","totalValueInUsd":"95799.4","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2647893","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"","customerAddress":"201\/301, CORPORATE ENCLAVE,B D SAWANT MARG, CHAKALA,"},{"dataSource":"API Import","activeIngredients":"TOLVAPTAN","year":"2021","qtr":"Q2","strtotime":1618943400,"product":"TOLVAPTAN AMORPHOUS (RE-PROCESSING AND RE-EXPORT VIDE SB NO: 8063947 DATED : 21.01.2021)","address":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI","city":"HYDERABAD,TELANGANA","supplier":"HIKMA PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"","customer":"AURORE LIFE SCIENCES","customerCountry":"INDIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"9000","totalValueFC":"55233.7","currency":"USD","unitRateINR":"685350","date":"21-Apr-2021","totalValueINR":"4112100","totalValueInUsd":"55233.7","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3657210","productDescription":"Re-export","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"H NO 7 58 214 SIDDARTHA NAGAR,DAMM AIGUDA HYDERABAD RANGAREDDI"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666204200,"product":"TOLVAPTAN","address":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI","city":"GARDEN CITY OFF WESTERN EXPR HIGHWA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"21.48","actualQuantity":"21.48","unit":"KGS","unitRateFc":"5500","totalValueFC":"118378","currency":"USD","unitRateINR":"453475","date":"20-Oct-2022","totalValueINR":"9740643","totalValueInUsd":"118378","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"2974546","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695061800,"product":"TOLVAPTAN (RE-PROCESSING AND RE-EXPORT VIDE SB NO:4052155 DATED:08\/09\/2022)","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"BIOFARMA ILAC, SANAYI VE TIC A.S","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"AURORE LIFE SCIENCES","customerCountry":"INDIA","quantity":"13.08","actualQuantity":"13.08","unit":"KGS","unitRateFc":"10000","totalValueFC":"134772.1","currency":"USD","unitRateINR":"855289.9","date":"19-Sep-2023","totalValueINR":"11187192.43","totalValueInUsd":"134772.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"7901126","productDescription":"Re-export","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"ISTANBUL","supplierAddress":"AKPINAR MAH.OSMANGAZI CADNO 156 (34885) SANCAKTEPE ISTANBULSDNF TR","customerAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698949800,"product":"TOLVAPTAN","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"36.58","actualQuantity":"36.58","unit":"KGS","unitRateFc":"5500","totalValueFC":"203314","currency":"USD","unitRateINR":"462825","date":"03-Nov-2023","totalValueINR":"16930138.5","totalValueInUsd":"203314","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"8610545","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"XUNQIAO LINHAI ZHEJIANG 317024 CHINA ZHEJIANGSDNF China","customerAddress":"21-22, KALPATARU SQUARE, KONDIVITA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705861800,"product":"TOLVAPTAN (TEST LICENCE FORM-11 NO.TL\/BZ\/23\/001385 DT.21\/12\/2023)","address":"MEDREICH HOUSE, NO12\/8,","city":"SEVA NAGAR, BANGALORE, KARNATAKA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MEDREICH","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"7000","totalValueFC":"10624.9","currency":"USD","unitRateINR":"588700","date":"22-Jan-2024","totalValueINR":"883050","totalValueInUsd":"10624.9","indian_port":"Bangalore Air","hs_no":"29349990","bill_no":"9775883","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"LTD. XUNQIAO, LINHAIZHEJIANG 317024SDNF CHINA","customerAddress":"MEDREICH HOUSE, NO12\/8,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710354600,"product":"TOLVAPTAN","address":"21-22, KALPATARU SQUARE, KONDIVITA","city":"ANDHERI (E), MUMBAI,MAHARASHTRA","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"37.48","actualQuantity":"37.48","unit":"KGS","unitRateFc":"5500","totalValueFC":"207913.1","currency":"USD","unitRateINR":"460625","date":"14-Mar-2024","totalValueINR":"17264225","totalValueInUsd":"207913.1","indian_port":"Bombay Air","hs_no":"29339990","bill_no":"2568080","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"XUNQIAO LINHAI ZHEJIANG 317024SDNFSDNF China","customerAddress":"21-22, KALPATARU SQUARE, KONDIVITA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"SAPROPTERINE API D01APIM2M9 BATCH NO.2412835 TOLVAPTAN","address":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM","city":"","supplier":"DIPHARMA","supplierCountry":"ITALY","foreign_port":"MILAN - MALPENSA","customer":"PAR PHARMACEUTICAL","customerCountry":"INDIA","quantity":"44.90","actualQuantity":"44.9","unit":"KGS","unitRateFc":"37500","totalValueFC":"1691300.2","currency":"USD","unitRateINR":"3200625","date":"02-Dec-2024","totalValueINR":"143708062.5","totalValueInUsd":"1691300.2","indian_port":"Madras Air","hs_no":"29339990","bill_no":"6993708","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"MILAN - MALPENSA","supplierAddress":"PIAZZA COL. C.BERNASCONI 5 6830 - CHIASSO SDNF SWITZERLAND","customerAddress":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734633000,"product":"GLYCOPYRROLATE ORAL BATCH NO 24010110 TOLVAPTAN","address":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM","city":"","supplier":"PCAS","supplierCountry":"FINLAND","foreign_port":"HELSINKI","customer":"PAR PHARMACEUTICAL","customerCountry":"INDIA","quantity":"13.54","actualQuantity":"13.54","unit":"KGS","unitRateFc":"17000","totalValueFC":"232837.6","currency":"USD","unitRateINR":"1461150","date":"20-Dec-2024","totalValueINR":"19783971","totalValueInUsd":"232837.6","indian_port":"Madras Air","hs_no":"29339990","bill_no":"7357453","productDescription":"API","marketType":"REGULATED MARKET","country":"FINLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"HELSINKI","supplierAddress":"MESSUKENTKTU 8 20210 TURKU SDNF FINLAND","customerAddress":"OLD NO.1\/63, NEW NO.1\/58 PUDUPAKKAM"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

01

ALKEM LABS LTD

India

BIO Partnering at JPM

Not Confirmed

02

ALKEM LABS LTD

India

BIO Partnering at JPM

Not Confirmed

03

HETERO LABS LTD V

India

Japan

Japan

BIO Partnering at JPM

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

01

Otsuka Australia Pharmaceutical Pty. Ltd

Australia

Australia

BIO Partnering at JPM

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Direct Compression

Co-Processed Excipients

Thickeners and Stabilizers

Disintegrants & Superdisintegrants

Lubricants & Glidants

Granulation

Controlled & Modified Release

Chewable & Orodispersible Aids

Taste Masking

Coating Systems & Additives

Film Formers & Plasticizers

Rheology Modifiers

Emulsifying Agents

Parenteral

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Tolvaptan Manufacturers

A Tolvaptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tolvaptan, including repackagers and relabelers. The FDA regulates Tolvaptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tolvaptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tolvaptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tolvaptan Suppliers

A Tolvaptan supplier is an individual or a company that provides Tolvaptan active pharmaceutical ingredient (API) or Tolvaptan finished formulations upon request. The Tolvaptan suppliers may include Tolvaptan API manufacturers, exporters, distributors and traders.

click here to find a list of Tolvaptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tolvaptan USDMF

A Tolvaptan DMF (Drug Master File) is a document detailing the whole manufacturing process of Tolvaptan active pharmaceutical ingredient (API) in detail. Different forms of Tolvaptan DMFs exist exist since differing nations have different regulations, such as Tolvaptan USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Tolvaptan DMF submitted to regulatory agencies in the US is known as a USDMF. Tolvaptan USDMF includes data on Tolvaptan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tolvaptan USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Tolvaptan suppliers with USDMF on PharmaCompass.

Tolvaptan JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Tolvaptan Drug Master File in Japan (Tolvaptan JDMF) empowers Tolvaptan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Tolvaptan JDMF during the approval evaluation for pharmaceutical products. At the time of Tolvaptan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Tolvaptan suppliers with JDMF on PharmaCompass.

Tolvaptan KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Tolvaptan Drug Master File in Korea (Tolvaptan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tolvaptan. The MFDS reviews the Tolvaptan KDMF as part of the drug registration process and uses the information provided in the Tolvaptan KDMF to evaluate the safety and efficacy of the drug.

After submitting a Tolvaptan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tolvaptan API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Tolvaptan suppliers with KDMF on PharmaCompass.

Tolvaptan WC

A Tolvaptan written confirmation (Tolvaptan WC) is an official document issued by a regulatory agency to a Tolvaptan manufacturer, verifying that the manufacturing facility of a Tolvaptan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tolvaptan APIs or Tolvaptan finished pharmaceutical products to another nation, regulatory agencies frequently require a Tolvaptan WC (written confirmation) as part of the regulatory process.

click here to find a list of Tolvaptan suppliers with Written Confirmation (WC) on PharmaCompass.

Tolvaptan NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tolvaptan as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Tolvaptan API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Tolvaptan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Tolvaptan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tolvaptan NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Tolvaptan suppliers with NDC on PharmaCompass.

Tolvaptan GMP

Tolvaptan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Tolvaptan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tolvaptan GMP manufacturer or Tolvaptan GMP API supplier for your needs.

Tolvaptan CoA

A Tolvaptan CoA (Certificate of Analysis) is a formal document that attests to Tolvaptan's compliance with Tolvaptan specifications and serves as a tool for batch-level quality control.

Tolvaptan CoA mostly includes findings from lab analyses of a specific batch. For each Tolvaptan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Tolvaptan may be tested according to a variety of international standards, such as European Pharmacopoeia (Tolvaptan EP), Tolvaptan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tolvaptan USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

Market Place

Home

Post Enquiry

Market Place

Find Tolvaptan manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers

15 USDMF

8 JDMF

8 EU WC

2 KDMF

6 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

78 FDF Dossiers

19 FDA Orange Book

37 Europe

12 Canada

10 Australia

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

3 Faran Shimi Pharmaceutical

10 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 DFE Pharma

3 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

18 Kerry

9 Microlex e.U

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

13 Roquette

1 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

9 Sigachi Industries

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders

23 Direct Compression

13 Co-Processed Excipients

11 Thickeners and Stabilizers

10 Disintegrants & Superdisintegrants

10 Lubricants & Glidants

9 Granulation

5 Controlled & Modified Release

5 Chewable & Orodispersible Aids

5 Taste Masking

3 Coating Systems & Additives

1 Film Formers & Plasticizers

1 Rheology Modifiers

1 Emulsifying Agents

1 Parenteral

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow

20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions

33 Finished Drug Prices

15 Annual Reports

MARKET PLACE

9 APIs

3 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents

5 US Exclusivities

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 8,898

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES